On Thursday 4th July, HCV Action held a National Hepatitis C ODN Stakeholder Event, in partnership with the British Viral Hepatitis Group. The event - HCV Action's biggest to date - brought ODN representatives together to discuss the opportunities and challenges associated with the recently-announced NHS England elimination deal.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 41 to 50 of 330 resources
-
HCV Action & BVHG National Hepatitis C ODN Stakeholder Event: Presentations
England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
Summary report: National Hepatitis C ODN Stakeholder Event
This report provides a summary of the the breakout sessions held during the HCV Action & British Viral Hepatitis Group National Hepatitis C ODN Stakeholder Event, which took place at the University of Warwick on 4th July 2019. The breakout sessions were held in two parts, the first focusing on problem identification and the second on identifying solutions, and focused on the following topics: community outreach; reaching ethnic minority groups; treating in prisons; and engaging with local commissioners & other partners.England 30 Jul 2019 Training, Reports & Research, Strategy & Planning PDF -
Surveillance of hepatitis C testing, diagnosis and treatment in Scotland, 2019 update
This Health Protection Scotland report outlines that there were 1,423 new diagnoses of hepatitis C antibody-positivity in Scotland in 2018, the lowest number of new hepatitis C antibody diagnoses in Scotland since 1996. It is estimated that approximately 21,000 individuals were living with chronic hepatitis C infection in Scotland by the end of 2018 and approximately 10,500 of these have been diagnosed. A total of 2,609 individuals were initiated onto hepatitis C treatment during financial year 2018/19.Scotland 23 Jul 2019 Reports & Research PDF -
Drug-related infectious diseases in Europe
This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.UK, Rest of World 16 Jul 2019 Reports & Research PDF -
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.Rest of World 09 Jul 2019 Reports & Research PDF -
Information for GPs on the Infected Blood Inquiry
This document from Public Health England provides information for GPs on the ongoing Infected Blood Inquiry, chaired by Sir Brian Langstaff. The document covers: why there is an Infected Blood Inquiry; what to advise if your patient thinks that they received blood in the 1970s/1980s; what to do if your patient is hepatitis C positive and is concerned a past transfusionUK 05 Jul 2019 Training, Reports & Research PDF -
Hepatitis C: Progress towards achieving elimination in Wales
Following an inquiry into hepatitis C, the Welsh Assembly Health, Social Care and Sport Committee published this report. The report makes four main recommendations to the Welsh Government: that the Welsh Government produces a comprehensive national elimination strategy for hepatitis C, with clear ambitious targets, and workforce planning built in, and provides sustainable funding until elimination is achieved; implementation of a targeted awareness raising campaign to reach out to at risk communities; to write to Local Health BoardWales 27 Jun 2019 Reports & Research, Strategy & Planning PDF -
WHO progress report on HIV, viral hepatitis and STIs 2019
The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.Rest of World 24 May 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C in England 2019 report
Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF -
Hepatitis C Annual Epidemiological Report for 2017
The European Centre for Disease Prevention and Control has published a new report on the prevalence of hepatitis C in Europe. The report indicates a 10% decrease in newly reported hepatitis C cases from 2016 to 2017, but also warns of the under-reporting of diagnosed cases and the variation of national testing practices impacting the reliability of this statistic. Headline figures show that 5.6 million Europeans live with chronic hepatitis C, with more than 31,000 recorded cases in 2017.Rest of World 05 Apr 2019 Reports & Research PDF